Drugmaker Shionogi testing coronavirus vaccine candidate

Drugmaker Shionogi testing coronavirus vaccine candidate

Isao Teshirogi, president of Japanese pharmaceutical maker Shionogi & Co., gives an interview in Osaka on Dec. 16, 2020. Shionogi has conducted clinical testing for its coronavirus vaccine candidate.

  • Product Code
  • ILEA000211162
  • Registered date
  • 2021/1/08 16:23:55
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2021 Kyodo News
  • Media size
  • 2806 × 2229 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 486.72(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Kobayashi Pharmaceutical dietary pills scandal

    Kobayashi Pharmaceutical dietary pills scandal

    Kobayashi Pharmaceutical Co. President Akihiro Kobayashi speaks at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
      Kobayashi Pharmaceutical dietary pills scandal

      Kobayashi Pharmaceutical dietary pills scandal

      Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (C) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
        Kobayashi Pharmaceutical dietary pills scandal

        Kobayashi Pharmaceutical dietary pills scandal

        Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (2nd from L) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
          Kobayashi Pharmaceutical dietary pills scandal

          Kobayashi Pharmaceutical dietary pills scandal

          Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (R) apologizes at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
            Daihatsu suspends domestic production over safety scandal

            Daihatsu suspends domestic production over safety scandal

            Photo taken from a Kyodo News helicopter on Dec. 26, 2023, shows a Daihatsu Motor Co. factory at its headquarters in Ikeda, Osaka Prefecture, western Japan. The small-car unit of Toyota Motor Corp. is suspending production at all domestic factories due to a safety testing scandal, with the halt lasting until at least the end of January.
              Daihatsu suspends domestic production over safety scandal

              Daihatsu suspends domestic production over safety scandal

              Photo taken from a Kyodo News helicopter on Dec. 26, 2023, shows a Daihatsu Motor Co. factory at its headquarters in Ikeda, Osaka Prefecture, western Japan. The small-car unit of Toyota Motor Corp. is suspending production at all domestic factories due to a safety testing scandal, with the halt lasting until at least the end of January.
                Daihatsu suspends domestic production over safety scandal

                Daihatsu suspends domestic production over safety scandal

                Photo taken on Dec. 26, 2023, shows the headquarters building of Daihatsu Motor Co. in Ikeda, Osaka Prefecture, western Japan. The small-car unit of Toyota Motor Corp. is suspending production at all domestic factories due to a safety testing scandal, a measure that will last until at least the end of January.
                  Daihatsu suspends domestic production over safety scandal

                  Daihatsu suspends domestic production over safety scandal

                  Employees of Daihatsu Motor Co. arrive at the company's headquarters in Ikeda, Osaka Prefecture, western Japan, on Dec. 26, 2023. The small-car unit of Toyota Motor Corp. is suspending production at all domestic factories due to a safety testing scandal, a measure that will last until at least the end of January.

                    Daihatsu to stop all vehicle shipments over improper safety testing

                    TOKYO, Dec. 20 Kyodo - Daihatsu Motor Co. said Wednesday it will stop all shipments at home and abroad after the Toyota Motor Corp. subsidiary found most of its car models were affected by improper vehicle safety tests. The move comes after the minivehicle maker acknowledged earlier this year data-rigging in collision tests for six of its models, including those sold in Thailand and Malaysia. A third-party panel it has set up identified 174 new counts of misconduct across 25 vehicle test items in addition to those already discovered, with the oldest one dating back to 1989, Daihatsu said, adding that it reported the findings to the transport ministry. (Kyodo)
                      Interview with Seven & i Holdings president

                      Interview with Seven & i Holdings president

                      Seven & i Holdings Co. President Ryuichi Isaka gives an interview in Tokyo on April 27, 2023.